Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Turkish Transition
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hunderfund, A. L.
Right arrow Articles by Petersen, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hunderfund, A. L.
Right arrow Articles by Petersen, R. C.
Related Collections
Right arrow Clinical trials Systematic review/meta analysis
Right arrow Alzheimer's disease
Right arrow MCI (mild cognitive impairment)
NEUROLOGY 2006;67:1764-1768
© 2006 American Academy of Neurology

Mortality in amnestic mild cognitive impairment

A prospective community study

A. L. Hunderfund, MD, R. O. Roberts, MD, MS, T. C. Slusser, BS, C. L. Leibson, PhD, Y. E. Geda, MD, R. J. Ivnik, PhD, E. G. Tangalos, MD and R. C. Petersen, PhD, MD

From the Departments of Health Sciences Research (R.O.R., C.L.L., R.C.P., T.C.S.), Neurology (R.C.P., A.L.H.), Psychiatry and Psychology (Y.E.G., R.J.I.), and Internal Medicine (E.G.T.), Mayo Clinic College of Medicine, Rochester, MN.

Address correspondence and reprint requests to Dr. Ronald C. Petersen, Mayo Clinic, Department of Neurology, 200 First Street SW, Rochester, MN 55905; e-mail: peter8{at}mayo.edu).

Objective: To assess the hazard of death in persons with and without amnestic mild cognitive impairment (aMCI).

Methods: From 1987 through 2003, persons with aMCI (n = 243) and an age- and gender-matched reference group of cognitively normal persons in Olmsted County, MN, were recruited through the Mayo Clinic Alzheimer’s Disease Patient Registry and followed prospectively through 2004. Survival was estimated using Kaplan-Meier survival curves, and the hazard of death for the aMCI cohort vs the reference cohort was estimated using Cox proportional hazards models.

Results: Over a median follow-up of 5.7 years, persons with aMCI had increased mortality (hazard ratio [HR] = 1.7; 95% CI: 1.3 to 2.3) vs reference subjects. The hazard of death by aMCI subtype was 1.5 in persons with single-domain aMCI (95% CI: 1.1 to 2.1) and 2.9 in persons with multiple-domain aMCI (95% CI: 1.9 to 4.6) vs reference subjects. Analyses restricted to aMCI cases showed an interaction between aMCI subtype and APOE-{varepsilon}4 allele status (p = 0.003). Among aMCI cases with an APOE-{varepsilon}4 allele, there was no difference in mortality between single- and multiple-domain aMCI (HR = 1.2; 95% CI: 0.6 to 2.3). However, among aMCI cases with no APOE-{varepsilon}4 allele, the hazard of death in multiple-domain aMCI was 4.6 (95% CI: 2.3 to 9.1) vs single-domain aMCI.

Conclusions: Amnestic mild cognitive impairment is associated with increased mortality, which is greater in multiple-domain aMCI than in single-domain aMCI. Mortality in aMCI subtypes may vary by APOE-{varepsilon}4 allele status.


Supported by grants from the National Institutes of Health (P50 AG16574, and U01 AG06786, R01 AR30582, K01 MH68531) and by the Robert H. and Clarice Smith and the Abigail van Buren Alzheimer’s Disease Research Program.

Disclosure: The authors report no conflicts of interest.

Received December 21, 2005. Accepted in final form July 27, 2006.




This article has been cited by other articles:


Home page
NeurologyHome page
B. Caracciolo, K. Palmer, R. Monastero, B. Winblad, L. Backman, and L. Fratiglioni
Occurrence of cognitive impairment and dementia in the community: A 9-year-long prospective study
Neurology, May 6, 2008; 70(19_Part_2): 1778 - 1785.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
M. Ganguli and R. C. Petersen
Mild Cognitive Impairment: Challenging Issues
Am J Geriatr Psychiatry, May 1, 2008; 16(5): 339 - 342.
[Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
K. A. Swanson and R. M. Carnahan
Dementia and Comorbidities: An Overview of Diagnosis and Management
Journal of Pharmacy Practice, August 1, 2007; 20(4): 296 - 317.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. L. Whitwell, R. C. Petersen, S. Negash, S. D. Weigand, K. Kantarci, R. J. Ivnik, D. S. Knopman, B. F. Boeve, G. E. Smith, and C. R. Jack Jr
Patterns of Atrophy Differ Among Specific Subtypes of Mild Cognitive Impairment
Arch Neurol, August 1, 2007; 64(8): 1130 - 1138.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.